XingXing Zang, M.Med, Ph.D.
M.Med: Shanghai Jiao Tong University School of Medicine
Anne T. Madsen, Ph.D.
Amit K Mishra, Ph.D.
Amit Mishra graduated in Biochemistry (H) from the University of Delhi, India. He was rewarded with fellowship and earned his PhD degree from South Asian University, New Delhi, India. During his PhD tenure, he identified three host proteins that act as restriction factors against Hepatitis B virus, and elucidated the mechanism involved in novel host restriction factor mediated inhibition of HBV replication as well as the counteraction mechanism employed by the virus to overcome the inhibitory host restriction proteins. He was also part of project including metabolic disorder non-alcoholic fatty liver disease, liver fibrosis, and hepatocellular carcinoma. In April 2023, he joined Prof. Zang’s lab and is currently working on novel immune checkpoints and metabolic pathways.
Christopher D. Nishimura, B.S.
Marc C. Pulanco, M.S.
Yunchao Shentu, B.S.
Yunchao Shentu obtained his B.S. in Pharmacy from Sichuan University, China in 2022. While at Sichuan University, he studied regulation mechanism of cardiac hypertrophy under the supervision of Professor Bisen Ding. After graduation, he furthered his research experience by joining the lab of Dr. Dehua Chang at the University of Tokyo, Japan, where he studied the three-dimensional culture of umbilical cord-derived mesenchymal stem cells. In the autumn of 2023, Yunchao commenced PhD program at Albert Einstein College of Medicine and joined the Zang Laboratory in the same year. In the Zang lab he is working on basic biology and translational immunotherapy of new immune pathways.
Roberto Alejandro (Alex) Sica, M.D.
Ankit Tanwar, Ph.D.
Ankit Tanwar previously worked as a Post-Doctoral Scientist (2018-2022) with Prof. Stanley at Albert Einstein College of Medicine. He was working on Role of Notch Glycosylation in Hematopoiesis. Dr. Tanwar received his Ph.D. degree in Toxicology from the Institute of Nuclear Medicine and Allied Sciences, New Delhi, India in 2018 followed by his master degree in Toxicology in 2014 and bachelor degree in Biochemistry from Shivaji College, University of Delhi, New Delhi, in 2012. He was a key worker of a team who coined the word "Herbal Informatics", which has been used for the initial screening of emergency-approved drug by DCGI: 2-Deoxy-D-glucose (2-DG) for combating the COVID-19 situation in India. He is also serving as an Editorial Board and Co-chair of committees (JoLS/SoLS, USA and JoVE, USA, etc). In July 2022, he joined Prof. Zang's Lab and he is co-mentored by Dr. Alex Sica (Department of Oncology) and Prof. Zang (Department of Microbiology & Immunology). He is currently working on the function and mechanism of CAR-T cell therapy and new immune checkpoints.
Jiabi Zhang, M.S.
Jiabi Zhang received her M.S. in Biochemistry and Molecular Biology from Sichuan University in 2018. While at Sichuan University, she mainly focused on exploring the mechanism and intervention of the Th17/ Treg (regulatory T cell) imbalance in the development of organ inflammation in autoimmune diseases, including rheumatoid arthritis. Then, she obtained her M.S. in Biomedical Sciences from the University of Utah in 2023. There, she studied diabetes and obesity, investigated bone morphogenetic protein endothelial regulator which is a marker of adipose progenitors and adipocytes and a positive modulator of adipogenesis. In August 2023 she started in the PhD program at Albert Einstein College of Medicine and joined the Zang lab. In the Zang lab she is working on the function and mechanisms of novel immune checkpoints.